2025-08-21 - Analysis Report
Okay, here's an analysis of Intuitive Surgical Inc. (ISRG) based on the provided data, formatted as a report:

## Intuitive Surgical Inc. (ISRG) Analysis

**Company Overview:** Intuitive Surgical Inc. designs, manufactures, and markets the da Vinci surgical system and related instruments and accessories.

### 1. Performance vs. S&P 500 (VOO)

**Key Numbers:**

*   ISRG Cumulative Return: 3.28%
*   VOO Cumulative Return: 37.28%
*   Absolute Deviation: -34.00%
*   Deviation Range: Max 127.7, Min -6.8
*   Current Deviation: 12.5
*   Relative Deviation: 14.3

**Analysis:**

ISRG has significantly underperformed the S&P 500 (VOO) based on cumulative returns. The negative absolute deviation (-34.00%) highlights this underperformance. A Relative Deviation of 14.3 indicates that the current deviation is near the lower end of its historical range relative to the S&P 500.

**Alpha/Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha  | Beta   | Cap(B) |
| ---------- | ------ | ------ | ------ | ------ | ------ |
| 2015-2017  | 0.0%   | 0.0%   | 0.0%   | 1.0    | 43.6   |
| 2016-2018  | 0.0%   | 0.0%   | 0.0%   | 1.0    | 57.2   |
| 2017-2019  | 0.0%   | 0.0%   | 0.0%   | 1.0    | 70.6   |
| 2018-2020  | 0.0%   | 0.0%   | 0.0%   | 1.0    | 97.8   |
| 2019-2021  | 5.0%   | 0.0%   | 4.0%   | 0.1    | 128.8  |
| 2020-2022  | -24.0%  | 69.3%  | -13.0% | 0.2    | 95.1   |
| 2021-2023  | -3.0%  | 72.5%  | -13.0% | 0.0    | 120.9  |
| 2022-2024  | 35.0%  | 72.5%  | 5.0%   | 0.1    | 187.1  |
| 2023-2025  | 29.0%  | 72.5%  | -14.0% | 0.0    | 172.2  |

**Analysis:**

*   **CAGR:** Fluctuating CAGR indicates periods of growth and contraction. Recent periods (2020-2025) show both significant losses and gains.
*   **MDD:** High Maximum Drawdown (MDD) values (69.3%~72.5% in recent periods) suggest significant risk and volatility.
*   **Alpha:** Negative Alpha values in some periods (e.g., 2020-2023, 2023-2025) indicate underperformance relative to the benchmark (S&P 500).
*   **Beta:** Low Beta values (close to 0.0 and 0.1) suggest the stock is not highly correlated with the market.

### 2. Recent Stock Price Movement

**Key Numbers:**

*   Current Price: 480.45
*   Previous Close: 479.20
*   Change: 0.26
*   5-Day Moving Average: 479.65
*   20-Day Moving Average: 482.25
*   60-Day Moving Average: 513.58

**Analysis:**

The stock price is slightly up from the previous close. The 5-day moving average is below the 20-day moving average, which is below the 60-day moving average. This suggests a potential short-term downward trend or consolidation phase.

### 3. Market Risk Indicators & Expected Return

**Key Numbers:**

*   Market Risk Indicator (MRI): 0.3316 (Low Risk)
*   RSI: 49.22
*   PPO: 0.3498
*   Hybrid Signal: Cash 0%, Buy 80% of cash (1 shares - Caution - MRI:0.33)
*   Recent (20-Day) Relative Deviation Change: -1.2 (Negative: Short-term decline)
*   Expected Return: 256.3% (Long-term, vs. S&P 500)

**Analysis:**

*   The Market Risk Indicator (MRI) suggests a low-risk environment.
*   RSI is near 50, indicating a neutral momentum.
*   The PPO is slightly positive, suggesting a mild uptrend, but needs further confirmation.
*   The Hybrid Signal recommends a partial buy, reflecting caution due to the MRI level.
*   The negative change in relative deviation confirms a short-term decline relative to the S&P 500.
*   The high expected return (256.3%) suggests significant potential outperformance over the long term, but this is based on a specific model and timeframe (2+ years).
*   The 'change': 0.26 is small, indicating no significant price surge or drop necessitating the mention of volatility.

### 4. Recent News & Significant Events

*   **[2025-08-18]:** Major business developments, regulatory changes, or market events affecting ISRG.
*   **[2025-08-20]:** Analyst discussions on ISRG's performance and outlook considering industry trends and global economic factors.
*   **[2025-08-19]:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-08-17]:** Market experts highlight risks and opportunities, advising monitoring of recent news and company announcements.

**Analysis:**

The recent news suggests a dynamic environment for ISRG, with potential catalysts for both positive and negative price movements. Investor caution and monitoring are advised.

### 5. Recent Earnings Analysis

| Date       | EPS  | Revenue      |
| ---------- | ---- | ------------ |
| 2025-07-23 | 1.84 | 2.44 B$      |
| 2025-04-23 | 1.95 | 2.25 B$      |
| 2024-10-18 | 1.59 | 2.04 B$      |
| 2024-07-19 | 1.48 | 2.01 B$      |
| 2025-07-23 | 1.48 | 2.01 B$      |

**Analysis:**

EPS and Revenue have generally been increasing, with a slight dip in the most recent duplication. This indicates solid growth and profitability, but continuous monitoring is still necessary.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
| ------------ | -------- | ------------- |
| 2025-06-30   | $2.44B  | 66.31%        |
| 2025-03-31   | $2.25B  | 64.69%        |
| 2024-12-31   | $2.41B  | 68.04%        |
| 2024-09-30   | $2.04B  | 67.41%        |
| 2024-06-30   | $2.01B  | 68.30%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE     |
| ------------ | --------- | ------- |
| 2025-06-30   | $17.85B  | 3.69%   |
| 2025-03-31   | $17.11B  | 4.08%   |
| 2024-12-31   | $16.43B  | 4.17%   |
| 2024-09-30   | $15.58B  | 3.63%   |
| 2024-06-30   | $14.71B  | 3.58%   |

**Analysis:**

*   **Revenue:** Demonstrates consistent growth over the past year.
*   **Profit Margin:** Remains strong, indicating efficient operations.
*   **Equity:** Increases steadily, reflecting retained earnings.
*   **ROE:** Fluctuates but remains healthy, indicating effective capital utilization.

### 7. Overall Summary

ISRG has underperformed the S&P 500 in recent times, exhibiting periods of volatility. Recent price action suggests a short-term consolidation phase, although the MRI indicates a low-risk environment. The hybrid signal favors partial buying, reflecting caution. The company showcases robust fundamentals through growing revenue, high profit margins, and increasing equity. However, investors should closely monitor recent news and analyst opinions and consider ISRG's volatile nature. The potential for long-term outperformance is high, but it comes with inherent risks.
